HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

M Rubinger Selected Research

sugar formulated recombinant FVIII

3/2008A prospective surveillance study of factor VIII inhibitor development in the Canadian haemophilia A population following the switch to a recombinant factor VIII product formulated with sucrose.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


M Rubinger Research Topics

Disease

1Hemophilia A (Haemophilia)
03/2008
1Multiple Myeloma
12/2002

Drug/Important Bio-Agent (IBA)

1human F8 proteinFDA Link
03/2008
1sugar formulated recombinant FVIIIIBA
03/2008
1Factor VIII (Coagulation Factor VIII)IBA
03/2008
1Sucrose (Saccharose)IBA
03/2008
1ancestimIBA
12/2002
1Filgrastim (Neupogen)FDA Link
12/2002
1Cyclophosphamide (Cytoxan)FDA LinkGeneric
12/2002